Abbott's SIMCOR(R) (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths

Abbott received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and ...

Defending Fish Oil, Criticizing Glaxo

Steven Salzberg wrote earlier this week about GlaxoSmithKline's marketing of fish oil, a supplement,

Pump up good cholesterol

What should I do to raise my HDL cholesterol besides get more omega-3 fatty acids in my diet? A. You may think we've gone off the deep end by suggesting raising your cholesterol to lower it, but the higher your good HDL is, the less trouble your lousy LDL cholesterol may be. It's extra important to increase your HDL if you're over 50. If you're a man over 60, underline that. Healthy HDL is your ...

JCI table of contents: July 26, 2010

( Journal of Clinical Investigation ) This release contains summaries, links to PDFs, and contact information for papers to be published July 26, 2010, in the JCI: "Reducing the health risks of obesity without serious side effects"; "Predicting drug responsiveness in cancer patients"; "Flushing out key limitations to a drug that protects against heart attack"; "Function of rare immune cell ...

No Firm Conclusions About HDL Cholesterol Can Be Drawn From JUPITER Sub-Analysis

The European Society of Cardiology (ESC) is concerned that interpretations of a paper about cholesterol, published in the Lancet (1), could act to deter ongoing research efforts into developing new therapeutic strategies to increase high density lipoprotein (HDL) cholesterol. Caution, the ESC experts advise, should be displayed in the interpretation of the results.In the Lancet study, Paul ...